HOSPITAL PHARMACY COMMUNICATION – NEWSLETTER

1. Introduction

A newsletter is a periodic publication used to communicate important information, updates, announcements, and educational content to a specific group of people.

In hospital pharmacy, a newsletter is an important communication tool used to disseminate drug-related information among pharmacists, doctors, nurses, hospital administrators, laboratory staff, dieticians, and other healthcare professionals.

Traditional methods of hospital communication include notices, bulletins, memoranda, notice boards, and committee meetings. Although these methods are useful, they may not always provide sufficient information to all hospital departments.

A hospital pharmacy newsletter helps overcome these limitations by providing organized, concise, and updated information about medicines, therapeutics, drug safety, and hospital pharmacy activities.

With the development of clinical pharmacy, pharmacy newsletters increasingly focus on therapeutics, pharmacokinetics, toxicology, adverse drug reactions, drug interactions, and rational drug use.

Definition: A hospital pharmacy newsletter is a periodic publication prepared by the hospital pharmacy department to communicate drug-related information, therapeutic updates, pharmacy policies, and educational material to healthcare professionals and other relevant audiences.

2. Objectives of a Hospital Pharmacy Newsletter

The main objectives are:

1. To improve communication between the pharmacy department and other hospital departments.
2. To disseminate updated information about drugs and therapeutics.
3. To educate healthcare professionals about the safe and rational use of medicines.
4. To communicate changes in hospital drug policies and procedures.
5. To provide information about newly approved medicines included in the hospital formulary.
6. To improve awareness of adverse drug reactions, drug interactions, and medication errors.
7. To communicate important decisions and recommendations of the Pharmacy and Therapeutics (P&T) Committee.
8. To encourage collaboration among pharmacists, doctors, nurses, dieticians, and other healthcare professionals.
9. To promote continuing professional education.
10. To improve patient care and medication safety.

3. Importance of a Hospital Pharmacy Newsletter

The pharmacy department has regular contact with many hospital services and is in a suitable position to support the dissemination of drug information.

A pharmacy newsletter helps:

• Provide consistent drug information to hospital staff.
• Inform staff about new medicines and therapeutic advances.
• Communicate changes in prescribing, dispensing, storage, and medication-use procedures.
• Improve awareness of drug interactions and adverse drug reactions.
• Encourage evidence-based prescribing and rational drug therapy.
• Support interdisciplinary communication and teamwork.
• Provide patient education materials when appropriate.

The newsletter should be accurate, concise, factual, impartial, and based on reliable sources.

4. Types of Newsletters

A. Printed Newsletter

A physical publication distributed to hospital departments and healthcare professionals.

Examples:

• Printed pharmacy bulletin.
• Drug information bulletin.
• Therapeutic update circular.

B. Digital or Online Newsletter

An electronic publication distributed through email, the hospital intranet, the hospital website, or other approved digital communication channels.

Examples:

• Monthly pharmacy update sent by email.
• PDF drug information bulletin.
• Digital newsletter containing medication safety alerts.

A newsletter is different from a regular newspaper because it is generally directed toward a defined audience and focuses on a particular organization, profession, or subject.

5. Titles of Pharmacy Publications

The title should be short, professional, relevant, and representative of the publication's contents.

Suitable Titles

• Pharmacy Bulletin
• Pharmacy News
• Therapeutic Notes
• Pharmacy Review

These titles clearly communicate the professional purpose of the publication.

Unsuitable Titles

Examples mentioned in traditional teaching material include:

• The Mortar and Pestle
• The Pill Rollers
• News Drugstore News
• News Capsules

Such titles may sound informal, ambiguous, or less clearly associated with a professional drug information publication. However, a creative title is not automatically unsuitable; the main consideration is whether it communicates the publication's purpose clearly and professionally.

6. Contents of a Hospital Pharmacy Newsletter

A hospital pharmacy newsletter should be educational as well as informative. Its contents should be organized into appropriate sections.

A. Editorial

The editorial is generally prepared by the chief pharmacist, pharmacy newsletter editor, or a member of the Pharmacy and Therapeutics Committee.

It may include:

• Introduction of new pharmacy procedures.
• Updates on medicine ordering, prescribing, dispensing, and storage.
• Discussion of medication safety issues.
• Important therapeutic developments.
• Reminders about compliance with established hospital policies.

The editorial should be brief, informative, and relevant to hospital practice.

B. New Drug Section

This section provides important information about newly approved medicines or medicines newly added to the hospital formulary.

It may include:

1. Generic name and drug class.
2. Indications and therapeutic uses.
3. Mechanism of action, when relevant.
4. Dosage and route of administration.
5. Important contraindications and precautions.
6. Adverse effects.
7. Clinically significant drug interactions.
8. Monitoring requirements.
9. Storage and administration instructions.
10. Manufacturer or supplier information, where relevant.

Drug information should be verified using authoritative references and approved product information.

C. Abstracts of Pharmacy and Therapeutics Committee Meetings

This section summarizes important decisions and recommendations of the Pharmacy and Therapeutics Committee.

It may include:

• Addition or removal of medicines from the hospital formulary.
• Changes in medicine-use policies.
• Formulary restrictions.
• Recommendations concerning antimicrobial use.
• Medication safety initiatives.
• Decisions regarding therapeutic guidelines.

Only approved and appropriate information should be circulated. Confidential discussions and sensitive patient information must not be disclosed.

D. Leading Articles

Leading articles are short educational articles written by pharmacists, physicians, clinical pharmacologists, or other specialists.

Topics may include:

• Recent advances in pharmacotherapy.
• Rational use of medicines.
• Pharmacokinetics and pharmacodynamics.
• Management of adverse drug reactions.
• Drug interactions.
• Antimicrobial stewardship.
• Toxicology and poisoning management.
• Current developments in clinical pharmacy.

Articles should be concise, evidence-based, and relevant to the professional interests of the readers.

E. General Section

This section may include other information of interest to hospital staff.

Examples include:

• Drug safety alerts.
• Government notifications relevant to medicines.
• Important public health updates.
• Summaries of research articles.
• Reports of unusual poisoning cases, with appropriate confidentiality safeguards.
• Medication error prevention strategies.
• Continuing education programmes.
• Pharmacy department achievements.
• Useful updates for nursing and laboratory personnel.

Topics of interest to dieticians, such as food–drug interactions, may also be included.

7. Role of Different Healthcare Professionals

A hospital pharmacy newsletter should address the information needs of different healthcare professionals.

Pharmacists

Provide drug information, formulary updates, medication safety alerts, and pharmacy policy changes.

Physicians

Contribute articles about therapeutic advances, prescribing practices, and clinical management.

Nurses

Provide information on medication administration, dose timing, monitoring, and prevention of administration errors.

Dieticians

Contribute information about food–drug interactions, nutritional considerations, and dietary advice relevant to medication use.

Laboratory Personnel

Contribute information about laboratory monitoring, therapeutic drug monitoring, and clinically relevant laboratory test interference.

Patients

May receive simplified educational information about medication adherence, safe medicine use, side effects, storage, and precautions.

Patient-facing content should use simple language and should be clearly separated from technical material intended for healthcare professionals.

8. Format and Duplication

The format of the newsletter depends on the requirements of the hospital, available resources, and intended readership.

A. Paper and Page Layout

• Use good-quality paper for printed copies.
• Select a suitable page size and readable font.
• Design an attractive title page.
• Use clear headings and subheadings.
• Arrange content into columns when appropriate.
• Use tables, illustrations, and symbols where they improve understanding.
• Maintain consistent formatting across issues.

Older pharmacy teaching material describes paper sizes such as 18 × 11 inches and the use of stencils and duplication equipment. These are historical printing methods rather than mandatory requirements for modern newsletters.

B. Stenciling and Duplication

Traditionally, newsletters were prepared using stencils and duplicated with available printing equipment. The material could be arranged longitudinally in two columns.

Modern alternatives include word-processing software, desktop publishing tools, PDF files, and digital newsletter platforms.

C. Digital Formatting

A digital newsletter should:

• Be easy to read on mobile phones and computers.
• Use clear headings and concise paragraphs.
• Include appropriate hyperlinks and references.
• Avoid unnecessarily large files.
• Protect confidential information.
• Provide accessible and readable content.

9. Distribution of the Newsletter

The newsletter should be distributed to all relevant recipients according to its intended purpose.

Traditional distribution includes:

1. Medical staff.
2. Pharmacy department staff.
3. Hospital administrative staff.
4. Nursing stations.
5. School of Nursing offices.
6. Nursing faculty.
7. Nurses' libraries.
8. Hospital libraries.
9. Other relevant clinical departments.

Modern distribution may include:

• Official hospital email.
• Hospital intranet.
• Approved internal communication systems.
• The hospital website.
• Printed copies in staff areas.
• Patient education areas, when the content is suitable for patients.

The distribution list should reflect the intended audience. A technical drug bulletin need not be distributed to every patient, whereas a patient education newsletter may be suitable for wider community distribution.

10. Frequency of Publication

A newsletter may be published according to the hospital's needs and available resources.

Common schedules include:

• Weekly.
• Monthly.
• Quarterly.
• Special issues for important drug safety alerts or therapeutic developments.

A consistent schedule helps readers know when to expect new information. Urgent medication safety information should not be delayed until the next routine issue.

11. Characteristics of a Good Newsletter

A good hospital pharmacy newsletter should be:

• Accurate: Information must be scientifically correct.
• Concise: Articles should avoid unnecessary details.
• Factual: Content should be supported by reliable evidence.
• Impartial: Information should be balanced and not misleading.
• Relevant: Topics should meet the needs of the intended readers.
• Readable: Language and layout should be easy to understand.
• Timely: Information should be updated when necessary.
• Professional: The title and presentation should reflect the publication's purpose.
• Confidential: Patient information and sensitive hospital material must be protected.
• Evidence-based: Important clinical recommendations should be supported by reliable references.

12. Evaluation of a Newsletter

The effectiveness of a pharmacy newsletter can be evaluated by:

1. Collecting feedback from readers.
2. Assessing whether readers find the information useful.
3. Reviewing readership and digital engagement statistics.
4. Asking whether the newsletter improves awareness of drug-related policies.
5. Identifying topics that readers would like to see in future issues.
6. Reviewing accuracy, relevance, and publication timeliness.

Reader feedback helps the editorial team improve both the content and presentation of future issues.

13. Example of a Hospital Pharmacy Newsletter

Title: Pharmacy Bulletin

Issue: October 2026
Department: Hospital Pharmacy

Editorial

This month's issue focuses on medication safety and the importance of following approved prescribing and dispensing procedures.

Drug Information

A brief evidence-based update on a medicine recently added to the hospital formulary, including its indications, dosage, important precautions, and monitoring requirements.

Medication Safety Corner

Five practical measures to reduce medication errors:

1. Verify the patient's identity.
2. Confirm the medicine, dose, route, and timing.
3. Check allergies and clinically significant interactions.
4. Communicate medication changes clearly.
5. Document medication administration and relevant monitoring.

Therapeutic Update

A short review of an important development in antimicrobial stewardship or rational drug use.

P&T Committee Update

A summary of approved formulary changes and relevant medication-use policy updates.

Nursing Practice Corner

Important precautions for safe medication administration and monitoring.

Patient Education Corner

Simple advice on taking medicines as prescribed, avoiding self-medication, and asking a healthcare professional before using new medicines.

References

Include the authoritative sources used to prepare the drug information and therapeutic articles.

Conclusion

A hospital pharmacy newsletter is an important tool for professional communication, drug information dissemination, continuing education, and medication safety. By providing accurate, concise, and relevant information to healthcare professionals and appropriate patient audiences, it supports collaboration among hospital departments and contributes to better medication-use practices.

The success of a newsletter depends on its scientific accuracy, professional presentation, suitable distribution, regular evaluation, and ability to meet the needs of its readers.

Developing Therapeutic Guidelines

Developing Standard Therapeutic Guidelines (STGs): Need, Importance, Steps and Implementation

1. Introduction

Standard Therapeutic Guidelines (STGs) are systematically developed clinical recommendations designed to assist healthcare professionals in selecting appropriate treatment for specific diseases or clinical conditions.

They are primarily intended for prescribers, including general practitioners, trainee physicians, and other healthcare professionals involved in patient care. STGs provide clear, practical, evidence-based, and up-to-date information regarding diagnosis, treatment selection, medicine dosage, duration of therapy, contraindications, adverse effects, monitoring, and referral criteria.

In simple terms, STGs act as a roadmap for rational treatment, helping healthcare professionals choose the most appropriate therapy for their patients.

2. Need for Standard Therapeutic Guidelines

The development of STGs is important for improving the quality, safety, consistency, and affordability of healthcare.

2.1 Improving the quality of patient care

Government agencies and professional organizations develop and promote therapeutic guidelines to improve treatment standards and patient outcomes.

STGs help healthcare professionals select appropriate treatments based on available scientific evidence.

2.2 Controlling healthcare costs

Healthcare resources are limited, particularly in developing countries where funding for healthcare services may be insufficient.

STGs promote rational prescribing, reduce unnecessary medication use, discourage inappropriate investigations, and encourage cost-effective treatment.

2.3 Promoting consistency in treatment

Different practitioners may select different treatment approaches for the same condition. STGs help establish a common, evidence-based standard of care while allowing appropriate adjustments for individual patients.

2.4 Promoting rational drug use

STGs encourage the appropriate selection, dosage, route, frequency, and duration of medicines. They also help reduce unnecessary polypharmacy and medication-related problems.

2.5 Supporting healthcare planning

STGs help healthcare administrators plan medicine procurement, formulate essential medicine lists, evaluate prescribing practices, and monitor the quality of healthcare services.

3. Examples of Therapeutic Guidelines

3.1 Joint National Committee guidelines

The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI), published in 1997, was developed with contributions from a multidisciplinary team representing areas such as medicine, nursing, nutrition, pharmacy, public health, and the National Heart, Lung, and Blood Institute.

It provided recommendations for the prevention, diagnosis, evaluation, and management of hypertension.

3.2 Indian hypertension guidelines

In 2001, Indian hypertension guidelines were endorsed jointly by professional organizations, including the Cardiology Society of India, the Hypertension Society of India, the Indian College of Physicians, and the Association of Physicians of India, as described in the source material.

These guidelines illustrate the importance of collaboration among specialists and professional organizations in developing treatment recommendations appropriate to clinical practice.

Note: Historical guideline names, organizational affiliations, and publication details should be verified against the original publications before formal citation.

4. Steps in Developing Standard Therapeutic Guidelines

The development of STGs involves nine major steps:

1. Identify group members for guideline development.
2. Identify and refine the problem.
3. Review the literature and existing recommendations.
4. Obtain opinions from experts.
5. Begin the information feedback process.
6. Coordinate resources to avoid duplication.
7. Assess the quality, relevance, variability, and strength of information.
8. Synthesize the information.
9. Summarize and disseminate the recommendations, focusing on measurable outcomes.

Step 1: Identify Group Members for Guideline Development

Developing a reliable guideline requires a multidisciplinary team with appropriate clinical, scientific, and methodological expertise.

An ideal group may contain approximately 6–15 members, as suggested in the source material. The appropriate size depends on the scope of the guideline and the expertise required.

The team may include:

• General practitioners
• Hospital consultants
• Medical specialists relevant to the disease
• Pharmacists and clinical pharmacologists
• Epidemiologists
• Health economists
• Public health professionals
• Guideline methodology specialists
• Representatives of patients or the public, where appropriate

Each member contributes a different perspective. Clinicians provide practical treatment knowledge, pharmacists contribute expertise in medicine selection and safety, epidemiologists assess population-level evidence, and health economists examine resource utilization.

Example: A guideline for hypertension may require physicians, cardiologists, pharmacists, nurses, epidemiologists, and public health experts.

A multidisciplinary team helps ensure that recommendations are clinically appropriate, scientifically reliable, practical, and relevant to patients.

Step 2: Identify and Refine the Problem

The next step is to select the disease, drug, or clinical problem for which a guideline is required.

Potential topics may be identified by considering:

• Major causes of morbidity and mortality
• Common diseases in the population
• Uncertainty regarding appropriate drug therapy
• Variations in prescribing practices
• Poor treatment outcomes
• Medication safety concerns
• Unnecessary healthcare expenditure

In a hospital, for example, a committee may identify frequent or inappropriate use of a particular medicine. It can analyze medicine utilization data to determine whether developing a guideline would improve prescribing practices.

After selecting the topic, the problem must be refined into specific clinical questions.

For example, instead of asking, “How should hypertension be treated?”, the committee may ask:

• How should hypertension be diagnosed?
• Which patients require immediate intervention?
• Which medicines are appropriate for initial treatment?
• How should treatment be monitored?
• When should a patient be referred?

Clearly defined questions help the team identify relevant evidence and develop focused recommendations.

Step 3: Review Literature and Existing Recommendations

The third step is to examine scientific literature, existing clinical guidelines, professional recommendations, and reliable online resources to determine the current standard of care.

A systematic review is an important method of identifying and assessing evidence.

It involves:

1. Defining a focused clinical question.
2. Searching relevant scientific databases.
3. Selecting studies according to predefined criteria.
4. Assessing the quality and risk of bias of the studies.
5. Extracting relevant findings.
6. Summarizing the evidence to answer the clinical question.

Methods used to identify and synthesize evidence include expert opinion, traditional literature reviews, systematic reviews, and meta-analyses.

A meta-analysis statistically combines results from suitable studies to estimate an overall effect.

High-quality evidence improves the reliability of recommendations. However, the quality of evidence must be assessed carefully, and the recommendations should also consider clinical relevance, safety, feasibility, and patient preferences.

Step 4: Obtain Opinions from Experts

Expert opinions are used to interpret available evidence and address questions for which strong research evidence is unavailable or incomplete.

Experts may help determine:

• Whether the evidence is applicable to local practice
• Which treatment options are clinically appropriate
• Whether recommendations are feasible
• What precautions and referral criteria are necessary

However, recommendations based solely on personal experience may be affected by bias or conflicts of interest.

Therefore, expert opinions should be collected systematically, conflicts of interest should be managed transparently, and recommendations should be supported by the best available evidence whenever possible.

Important principle: Expert judgment complements scientific evidence; it should not unnecessarily replace stronger evidence.

Step 5: Begin the Information Feedback Process

Information feedback involves providing healthcare professionals with information about their clinical practice so that they can compare it with recommended standards or the practices of other clinicians and hospitals.

Feedback may include:

• Prescribing audit reports
• Medicine utilization data
• Treatment outcome reports
• Comparisons with recommended standards
• Reports on adverse drug reactions

Example: A hospital may discover that many patients with a particular condition receive unnecessary antibiotics. Feedback to prescribers can help identify the problem and encourage more rational prescribing.

Feedback should be constructive, confidential where appropriate, and focused on improving patient care rather than merely criticizing practitioners.

Step 6: Coordinate Resources to Avoid Duplication

Guideline development requires considerable time, funding, personnel, and technical expertise.

Therefore, organizations should coordinate available resources and examine existing guidelines before preparing new ones.

Developing a completely new guideline may be difficult for a local healthcare facility because it may lack sufficient research, clinical, managerial, or methodological resources.

An effective approach is often to adapt an existing, high-quality guideline to local needs.

Adaptation should consider:

• Local disease patterns
• Available medicines
• Healthcare infrastructure
• Medicine costs
• Local resistance patterns, where relevant
• Patient preferences
• Available diagnostic facilities
• Applicable national policies

Cost-effectiveness is also important. A treatment's value depends on its clinical benefits, costs, available alternatives, and the resources of the healthcare system.

Step 7: Assess the Quality, Relevance, Variability, and Strength of Information

After collecting the evidence, the development team must critically assess its quality and relevance.

Important considerations include:

Quality: Was the study designed and conducted appropriately?

Relevance: Does the evidence apply to the patients and healthcare setting for which the guideline is being developed?

Variability: Do different studies produce similar or conflicting results?

Strength of evidence: How confident can we be in the findings?

Risk of bias: Could errors in study design, conduct, or reporting have affected the results?

Evidence can be graded using an established framework, such as GRADE, which considers the certainty of evidence and supports transparent development of recommendations.

High-certainty evidence generally provides greater confidence in estimated treatment effects. However, the strength of a recommendation also depends on factors such as benefits, harms, patient values, and resource requirements.

Step 8: Synthesize the Information

Evidence synthesis involves bringing together the findings from relevant studies and translating them into practical clinical recommendations.

This is a critical stage because the committee must decide how the available evidence should guide treatment.

The process includes:

• Comparing treatment options
• Evaluating benefits and harms
• Considering medicine safety
• Assessing cost-effectiveness
• Considering patient preferences
• Evaluating the feasibility of implementation
• Formulating clear recommendations

For example, when several medicines are available for a condition, the committee may recommend one as the preferred initial option and identify alternatives for patients who cannot tolerate it or have contraindications.

Recommendations should clearly distinguish between strong evidence, limited evidence, and areas where expert consensus is required.

Transparent methods improve the credibility, acceptability, and usefulness of the guideline.

Step 9: Summarize and Disseminate the Information

The final recommendations must be presented in a clear, accessible, and practical format.

The way a guideline is presented affects how easily healthcare professionals can understand and use it.

Common formats include:

• Complete guideline manuals
• Summary documents
• Quick-reference sheets
• Treatment algorithms and flowcharts
• Posters
• Pocket manuals
• Electronic guidelines
• Clinical decision-support tools

A good guideline should provide essential information without unnecessary complexity.

It should clearly describe the clinical condition, diagnostic criteria, treatment objectives, medicines of choice, doses, duration, contraindications, adverse effects, monitoring, patient education, and referral criteria.

After publication, the guideline should be distributed to healthcare facilities and supported by training, supervision, monitoring, and periodic revision.

5. Important Principles for Developing STGs

A successful STG should follow these principles:

1. Evidence-based: Recommendations should be supported by reliable scientific evidence.
2. Patient-centered: Patient preferences, safety, and individual circumstances should be considered.
3. Cost-effective: Treatments should provide appropriate clinical benefits relative to their costs.
4. Practical: Recommended medicines and diagnostic services should be reasonably accessible.
5. Clear and simple: Healthcare professionals should be able to use the guideline easily.
6. Multidisciplinary: Relevant professionals should contribute to development.
7. Transparent: Methods, evidence, limitations, and conflicts of interest should be disclosed.
8. Dynamic: Guidelines should be reviewed and updated as evidence changes.
9. Adaptable: Recommendations should be appropriate to the healthcare setting.

6. Advantages of Standard Therapeutic Guidelines

For healthcare professionals

• Provide a standard approach to treatment.
• Support clinical decision-making.
• Promote rational prescribing.
• Improve consistency and quality of care.
• Reduce unnecessary medicine use.
• Encourage appropriate monitoring and referral.

For healthcare administrators

• Support evaluation of prescribing quality.
• Assist medicine procurement and supply planning.
• Help control unnecessary healthcare expenditure.
• Support implementation of disease-control programmes.
• Provide measurable standards for clinical audits.

For patients

• Promote appropriate and safer treatment.
• Improve understanding of medicines and treatment plans.
• Encourage consistent standards of care.
• Support better use of healthcare resources.

7. Limitations of Standard Therapeutic Guidelines

Despite their benefits, STGs have certain limitations.

Inaccurate or outdated information

Guidelines based on weak evidence or outdated recommendations may result in inappropriate treatment.

Time and resource requirements

Developing, reviewing, distributing, and updating guidelines requires significant resources.

Risk of rigid application

A practitioner may follow a guideline without considering the patient's individual circumstances.

Implementation difficulties

Healthcare facilities may lack recommended medicines, diagnostic facilities, training, or staff.

Limited applicability

A guideline developed for one population may not be fully applicable to another population or healthcare setting.

Therefore, STGs should support—not replace—clinical judgment. Individual patient characteristics, contraindications, comorbidities, and treatment response must always be considered.

8. Implementation, Monitoring, and Evaluation

Publication alone does not guarantee that a guideline will improve patient care.

Successful implementation requires:

1. Official dissemination and institutional support.
2. Initial training before implementation.
3. Access to printed or electronic reference materials.
4. Reinforcement training when required.
5. Availability of recommended medicines and diagnostic services.
6. Regular supervision and clinical audits.
7. Monitoring of treatment outcomes.
8. Identification of barriers to adherence.
9. Periodic revision of recommendations.

Plan–Do–Study–Act (PDSA) Cycle

The Plan–Do–Study–Act cycle is a quality-improvement method that can help evaluate and improve guideline implementation.

Plan: Identify a problem and plan a change.

Do: Implement the change on a small scale.

Study: Examine the results and compare them with the expected outcomes.

Act: Adopt the change, modify it, or repeat the cycle.

For example, a hospital may introduce an antibiotic prescribing guideline, audit prescribing practices, evaluate antibiotic use and patient outcomes, and revise its implementation strategy based on the findings.

Evaluating implementation failures is important because it helps identify barriers and improve practitioner acceptance and adherence.

9. Conclusion

Standard Therapeutic Guidelines are essential tools for promoting rational prescribing, improving the quality of patient care, and using healthcare resources efficiently.

Their development requires a multidisciplinary team, a clearly defined clinical problem, systematic assessment of evidence, expert interpretation, careful synthesis, and clear dissemination.

However, the effectiveness of an STG depends not only on its scientific quality but also on its implementation, accessibility, monitoring, and regular updating.

The central principle is simple: develop evidence-based recommendations, adapt them to clinical practice, evaluate their outcomes, and continuously improve them to provide safe, effective, and cost-effective patient care.

Quick Revision: Nine Steps of STG Development

1. Identify the guideline development group.
2. Identify and refine the problem.
3. Review the literature and existing recommendations.
4. Obtain expert opinions.
5. Begin the information feedback process.
6. Coordinate resources.
7. Assess evidence quality and relevance.
8. Synthesize the information.
9. Summarize, disseminate, monitor, and improve the recommendations.

RESEARCH AND ETHICS COMMITTEE

1. Introduction

Research involving human participants must be conducted according to accepted scientific and ethical principles. A Research Ethics Committee reviews proposed research to ensure that the rights, safety, dignity, privacy, and well-being of research participants are protected.

Depending on the institution and jurisdiction, such a committee may be called:

• Institutional Ethics Committee (IEC)
• Institutional Review Board (IRB)
• Ethics Review Board (ERB)
• Research Ethics Committee (REC)

The terminology may differ, but the fundamental purpose is the ethical review and oversight of research involving human participants.

2. Definition of Research

Research is a systematic investigation designed to develop or contribute to generalisable knowledge.

3. Human Subject/Research Participant

A human research participant is a living individual about whom a researcher obtains information or data through:

• Interaction
• Intervention
• Clinical examination
• Collection of biological material, where applicable
• Access to identifiable private information

4. Research Ethics Committee – Definition

A Research Ethics Committee/Institutional Ethics Committee is an independent multidisciplinary body consisting of scientific and non-scientific members that reviews research proposals involving human participants to ensure protection of their rights, safety, dignity, privacy, and well-being.

The committee should conduct its review independently and free from inappropriate bias or influence.

5. Composition of Ethics Committee

An ethics committee should have a multidisciplinary composition.

A typical committee includes:

1. Medical/clinical professional
2. Scientist/researcher
3. Pharmacist, where appropriate
4. Nurse or other healthcare professional
5. Legal expert
6. Social worker/community representative
7. Non-scientific/lay person
8. Member of either sex as appropriate to ensure diversity
9. Independent member/external expert where required

Minimum membership

Your source states at least five members, with representation from different disciplines.

Important characteristics:

• Multidisciplinary
• Scientific and non-scientific representation
• Appropriate gender representation
• Knowledge of ethics
• Knowledge of relevant laws and regulations
• Research experience

6. Main Roles and Responsibilities of IEC/IRB/ERB

1. Protection of participants

Safeguard the:

• Dignity
• Rights
• Safety
• Privacy
• Well-being

of research participants.

2. Ethical and scientific review

Review research proposals to determine whether:

• Scientific requirements are appropriate.
• Ethical principles are followed.
• Risks are reasonable in relation to anticipated benefits.
• Participant selection is appropriate.
• Informed consent is properly addressed.

3. Review of informed consent

Ensure that appropriate information is provided to participants and that informed consent procedures are ethically and scientifically appropriate.

4. Consideration of local values

Ensure that research follows recognised ethical and scientific standards while considering relevant:

• Local community values
• Customs
• Cultural considerations
• Applicable laws and regulations

5. Written decisions

The committee should provide its decision in writing, clearly identifying:

• Research project/trial
• Documents reviewed
• Date of review
• Approval/favourable opinion
• Required modifications, if any
• Disapproval, where applicable

6. Continuing review

The committee should review ongoing research at appropriate intervals according to applicable requirements.

This may include review of:

• Safety reports
• Protocol amendments
• Informed consent amendments
• Important new information
• Serious or unexpected ethical/safety issues

7. Additional information

If additional information is necessary to protect participants, the committee may require researchers to provide appropriate information to participants.

8. Non-therapeutic research

For non-therapeutic research, the committee should ensure that relevant ethical and regulatory requirements are adequately addressed, particularly where consent involves legally authorised representatives.

7. FUNCTIONS OF ETHICS COMMITTEE

The committee works according to written Standard Operating Procedures (SOPs).

Important functions include:

• Review research protocols.
• Review informed consent documents.
• Review participant information sheets.
• Review investigator qualifications where applicable.
• Review risk-benefit considerations.
• Review participant recruitment procedures.
• Review confidentiality and privacy safeguards.
• Review protocol amendments.
• Review safety information.
• Conduct continuing review.
• Maintain appropriate records.
• Provide written decisions.
• Ensure compliance with applicable ethical and regulatory requirements.

8. Documents Required for IEC Review

Important documents include:

1. Research protocol

Detailed study plan describing:

• Objectives
• Study design
• Methodology
• Participants
• Inclusion/exclusion criteria
• Procedures
• Statistical plan
• Risk-benefit considerations

2. Case Report Form (CRF)

Used for systematic collection of study data.

3. Participant Information Sheet (PIS)

Provides study-related information to potential participants.

4. Informed Consent Form (ICF)

Documents voluntary informed consent.

5. Investigator's Brochure (IB)

Contains relevant information about an investigational product, particularly in clinical trials.

6. Participant recruitment materials/procedure

Describes how participants will be approached and recruited.

Other documents may include

• Questionnaires
• Data collection forms
• Patient diaries
• Advertisements/recruitment materials
• Safety reports
• Previous ethics approval documents
• Protocol amendments
• Relevant regulatory documents

9. Records Maintained by Ethics Committee

According to your provided material, documents maintained according to the committee's SOP may include:

• Ethics Committee SOPs
• Correspondence with investigators
• Meeting agendas and minutes
• Dates and times of meetings
• Research proposals
• Participant information sheets
• Informed consent forms
• Committee decisions
• Amendments
• Continuing-review records

Record-retention periods should follow the applicable institutional and regulatory requirements rather than relying on one universal period.

10. Education and Training of Ethics Committee Members

Continuous education of ethics committee members is important.

Training should cover:

Ethics

• Principles of research ethics
• Informed consent
• Confidentiality
• Vulnerable populations
• Risk-benefit assessment

Law and regulations

Members should understand relevant:

• National regulations
• Institutional policies
• Research guidelines
• Legal requirements

Science

Members should understand basic:

• Research methodology
• Study designs
• Statistics
• Clinical research concepts

Communication and conflict management

Training should also include:

• Communication skills
• Conflict resolution
• Ethical deliberation
• Case discussion

Continuing education

Members may participate in:

• Workshops
• Conferences
• Training programmes
• Expert lectures
• Case discussions
• Relevant scientific literature review

11. Operations and Methods of Ethics Committee

The committee should establish:

1. Purpose and scope of the committee.
2. Roles and responsibilities of members.
3. Membership and selection procedures.
4. Responsibilities of the Chairperson.
5. Meeting procedures.
6. Submission and review procedures.
7. Decision-making procedures.
8. Conflict-of-interest management.
9. Confidentiality of committee documents.
10. Continuing education and training.
11. Record-keeping procedures.
12. Continuing review of approved research.

Meetings

The committee should meet according to its SOP and institutional requirements.

Applications for ethical review are commonly submitted by investigators/researchers, with the required supporting documents.

12. Types/Models of Hospital Ethics Committees

Your source describes three broad perspectives.

Model	Main feature	Important consideration
Professional model	Mainly healthcare professionals/physicians	Provides professional ethical expertise but may give less attention to wider community perspectives
Organisational model	Established/supported by hospital administration	Integrates ethical considerations into institutional policies but requires appropriate independence
Social/community model	Includes broader community representation	Promotes wider and more participatory ethical discussion

These are conceptual models, and actual committees may combine features of more than one model.

13. Functions of Clinical/Hospital Ethics Committee

A Clinical/Hospital Ethics Committee may assist the institution with:

1. Bioethics education.
2. Ethical evaluation of difficult clinical cases.
3. Providing ethics consultation.
4. Developing institutional ethical guidelines and policies.
5. Addressing fair and equitable allocation of resources.
6. Supporting community-oriented ethical initiatives.
7. Promoting patient participation in healthcare decision-making.
8. Addressing conflicts involving patients, relatives, healthcare professionals, and institutional interests.
9. Supporting ethically appropriate institutional policies.
10. Conducting or supporting bioethics-related educational or research activities.
11. Promoting bioethics awareness among healthcare institutions.
12. Facilitating discussion of ethical issues related to healthcare financing.
13. Contributing ethical perspectives to public-health issues.
14. Providing ethical input into organ transplantation policies.

Important distinction

Clinical Ethics Committee ≠ Research Ethics Committee

• Clinical Ethics Committee: primarily deals with ethical problems arising in patient care and clinical decision-making.
• Research Ethics Committee/IEC: primarily reviews research involving human participants and protects research participants.

This distinction is very important for examinations.

14. Ethics Consultation

Ethics consultation may be provided through:

• An individual ethics consultant
• An advisory/ombudsman team
• A subcommittee of the ethics committee

The purpose is to assist healthcare professionals and patients in resolving ethical issues without unnecessarily interfering with the patient–physician relationship.

15. Financial Resources of Ethics Committee

Ethics committee members may serve as part of their institutional responsibilities, depending on institutional policy.

Resources may be required for:

• Meeting facilities
• Administrative/secretarial support
• Documentation and record keeping
• Training and education
• Access to scientific and ethical literature
• Conferences and workshops

Adequate administrative and educational support helps the committee function effectively.

RESEARCH ETHICS COMMITTEE

Research proposal

↓

IEC/IRB/ERB review

↓

Scientific + Ethical review

↓

Risk–benefit + Consent + Participant protection

↓

Approval / Modifications / Disapproval

↓

Continuing review

↓

Protection of research participants

Remember the core responsibility:

“Rights + Safety + Dignity + Privacy + Well-being of participants”

Hospital Committes - Infection control committe

HOSPITAL COMMITTEES

A hospital committee is a group of healthcare professionals and/or administrative personnel within a hospital that addresses a particular aspect of patient care, hospital management, or institutional functioning.

Hospital committees may deal with:

• Patient care and clinical services
• Financial matters
• Operational management
• Drug and therapeutic management
• Infection prevention
• Research and ethics
• Quality assurance
• Biomedical waste management
• Medical records
• Blood transfusion services

Major Hospital Committees

1. Pharmacy and Therapeutics Committee (PTC)
2. Management Committee
3. Committee on Medical Services
4. Bioethics/Clinical Ethics Committee
5. Infection Control Committee (ICC)
6. Quality Assurance/Quality Control Committee
7. Waste Management Committee
8. Medical Records Committee
9. Blood Transfusion Committee
10. Research/Ethics Committee

I. INFECTION CONTROL COMMITTEE (ICC)

1. Introduction

The risk of infection is always present in a hospital. Patients may acquire infections before admission or during their stay in the hospital. Healthcare workers and visitors may also be exposed to infectious agents.

Antibiotics are among the most frequently prescribed anti-infective medicines in hospitals. However, inappropriate or unnecessary antibiotic use can contribute to adverse effects, increased healthcare costs, and the development and spread of antimicrobial resistance.

Inappropriate antibiotic use may occur because of:

• Unnecessary antibiotic therapy
• Incorrect drug selection
• Inappropriate dose
• Incorrect duration of treatment
• Unreasonable antibiotic prophylaxis
• Failure to obtain appropriate microbiological investigations when indicated

Therefore, hospitals require an effective infection prevention and control programme, supported by an Infection Control Committee and Infection Control Team.

2. Hospital-Acquired and Community-Acquired Infection

A. Community-acquired infection

An infection that is present or incubating before the patient is admitted to the hospital is generally considered a community-acquired infection.

B. Hospital-acquired infection / Nosocomial infection

A healthcare-associated infection (HAI) is an infection associated with receiving healthcare that was not present or incubating at the time of admission.

Hospital-associated infections may:

• Develop during hospitalisation
• Become apparent after a period following admission
• Become apparent after discharge when the infection was acquired during healthcare
• Include certain occupational infections among healthcare workers

Important: The commonly used 48-hour criterion is a traditional surveillance rule for some hospital-acquired infections, not a universal definition for every HAI.

3. Definition of Infection

Infection is the invasion and multiplication of pathogenic microorganisms such as bacteria, viruses, fungi, protozoa, or other infectious agents in the body, which may produce tissue injury or disease.

Infection may be:

• Localised – confined to a particular area
• Generalised/systemic – spread throughout the body

Common manifestations may include:

• Pain
• Swelling
• Redness
• Fever
• Increased pulse rate
• Functional disturbances
• Leukocytosis

4. Factors Influencing Hospital Infection

Three major factors influence the occurrence of hospital infection:

1. Microbial agent

Important characteristics include:

• Type of organism
• Virulence
• Infective dose
• Antimicrobial resistance
• Ability to survive in the environment

2. Patient susceptibility

Risk is increased by factors such as:

• Extremes of age
• Immunosuppression
• Chronic diseases
• Malnutrition
• Surgical procedures
• Invasive devices
• Prolonged hospitalisation

3. Environmental factors

Examples include:

• Contaminated equipment
• Poor hand hygiene
• Inadequate sterilisation
• Poor environmental cleaning
• Contaminated food or water
• Improper waste management
• Inadequate isolation facilities

Easy memory:

Infection risk = Agent + Host + Environment

5. Modes of Transmission

A. Endogenous infection

An endogenous infection occurs when microorganisms that are normally present in or on the patient become pathogenic or cause infection because of changes in the patient's condition.

Contributing factors may include:

• Change in normal microbial habitat
• Damage to skin or mucous membranes
• Immunosuppression
• Invasive procedures
• Inappropriate antibiotic use

Example: Normal intestinal flora causing infection following surgery or severe immunosuppression.

B. Exogenous infection / Cross-infection

An exogenous infection occurs when the infectious organism comes from an external source.

Common sources include:

• Healthcare workers
• Visitors
• Other patients
• Contaminated equipment
• Environment
• Food or water

Hands of healthcare workers are an important route of transmission, making hand hygiene a fundamental infection-prevention measure.

6. Infection Control Programme (ICP)

An effective Infection Control Programme is an important component of quality healthcare and patient safety.

The programme generally operates through two major bodies:

1. Infection Control Committee (ICC)

Advisory/policy-making body

↓

Develops and approves policies, reviews surveillance information and provides direction.

2. Infection Control Team (ICT)

Operational/implementation body

↓

Implements infection-control policies, conducts surveillance, training, audits and investigations.

Overall structure

Hospital Management

↓

Infection Control Committee

↓

Infection Control Team

↓

Infection Control Manual + Surveillance + Prevention + Staff Training

7. Infection Control Committee – Definition

The Infection Control Committee (ICC) is a multidisciplinary hospital committee responsible for planning, approving, monitoring, evaluating, and improving infection prevention and control activities and for recommending corrective actions.

It includes representatives from relevant clinical, nursing, microbiology, pharmacy, administrative, and support departments.

8. Constitution/Composition of ICC

The membership should reflect the clinical services and administrative structure of the hospital.

Core members

1. Chief Executive/Hospital Administrator or nominated representative
2. Hospital Microbiologist/Infection Control Doctor – often the Chairperson
3. Infection Control Nurse (ICN)
4. Infectious Disease Physician, if available
5. Director of Nursing or representative
6. Occupational Health Physician, if available
7. Representatives from major clinical specialties
8. Hospital Pharmacist/Pharmacy representative
9. CSSD representative
10. Maintenance/Engineering representative
11. Housekeeping representative
12. Biomedical waste management representative, where applicable

Important principle

The exact composition may vary according to:

• Size of hospital
• Type of services
• Available resources
• Local requirements

9. Authority of Infection Control Team

The Infection Control Team should:

• Have sufficient authority to implement the infection-control programme.
• Have a direct reporting relationship with senior hospital administration.
• Have access to necessary resources and information.
• Be responsible for day-to-day infection-control activities.
• Prepare an annual infection-control work plan.
• Have appropriate expertise and training.

10. Tasks/Functions of Infection Control Committee

1. Annual infection-control plan

• Review and approve the annual infection-control plan.
• Establish priorities and objectives.

2. Infection-control policies

• Review and approve infection-control policies.
• Ensure policies are evidence-based and periodically updated.

3. Identify areas requiring intervention

Review surveillance data to identify:

• High-risk areas
• Increased infection rates
• Problems in clinical practice
• Potential outbreaks

4. Support the Infection Control Team

• Provide institutional support.
• Direct resources towards identified problems.
• Ensure availability of appropriate supplies.

5. Surveillance

• Review epidemiological surveillance data.
• Monitor healthcare-associated infections.
• Identify trends and areas requiring intervention.

6. Promote improved practices

Assess and promote good infection-control practices at all levels of the healthcare facility.

7. Staff training

Ensure appropriate training in:

• Infection prevention
• Hand hygiene
• PPE
• Isolation precautions
• Sterilisation
• Safe clinical practices

8. Safety management

Promote safety measures for:

• Patients
• Healthcare workers
• Visitors

9. New technology and devices

Review infection-related risks associated with new technologies, procedures, and medical devices before their introduction when appropriate.

10. Outbreak investigation

Review and provide input into investigation and control of suspected outbreaks.

11. Infection-control manual

Develop, review, approve, and periodically update the hospital's Infection Control Manual.

12. Monitoring and evaluation

Monitor and evaluate the effectiveness of the infection-control programme and recommend corrective actions.

11. Role of Infection Control Team

The Infection Control Team is responsible for implementation and day-to-day activities.

Major functions

1. Develop an annual infection-control plan with clearly defined objectives.
2. Develop written infection-control policies and procedures.
3. Regularly evaluate and update policies.
4. Supervise and monitor daily patient-care practices designed to prevent infection.
5. Ensure availability of appropriate infection-control supplies.
6. Organise an epidemiological surveillance programme.
7. Pay particular attention to high-risk areas for early detection of outbreaks.
8. Educate all categories of hospital staff regarding infection-control policies and procedures.
9. Investigate suspected outbreaks.
10. Provide infection-control reports to the ICC.

12. Infection Control Manual

Every hospital should have an Infection Control Manual containing recommended infection-prevention and patient-care practices.

It should include policies/procedures relating to areas such as:

• Standard precautions
• Hand hygiene
• PPE
• Isolation precautions
• Sterilisation and disinfection
• Safe injection practices
• Biomedical waste management
• Occupational exposure
• Environmental cleaning
• Outbreak management

Development

Infection Control Team → Develops/updates manual

↓

Infection Control Committee → Reviews and approves

13. Scope of Infection Control

The primary aim is to prevent the spread of infection within healthcare facilities.

Standard precautions

Standard precautions should be applied to all patients, regardless of their suspected or confirmed infection status.

They are particularly important whenever healthcare workers may be exposed to:

• Blood
• Body fluids
• Non-intact skin
• Mucous membranes
• Potentially contaminated materials

Important components include:

• Hand hygiene
• Appropriate PPE
• Respiratory hygiene
• Safe injection practices
• Sharps safety
• Appropriate cleaning and disinfection

14. Antibiotic Policy and Infection Control

A hospital antibiotic policy should promote rational antimicrobial use.

Essential principles

1. Use antibiotics only when clinically indicated

↓

2. Identify the likely pathogen

↓

3. Obtain appropriate specimens for culture and susceptibility testing when indicated

↓

4. Select an appropriate antibiotic

Selection should consider:

• Likely/confirmed organism
• Site of infection
• Patient factors
• Safety
• Local resistance patterns
• Cost
• Ease of administration

↓

5. Use appropriate dose and duration

↓

6. Prefer oral therapy when clinically appropriate

↓

7. Review therapy periodically

This supports antimicrobial stewardship and helps limit antimicrobial resistance.

15. Antibiotic Use Review (AUR)

Antibiotic Use Review (AUR) is the periodic assessment of antibiotic prescribing and utilisation.

It may evaluate:

• Indication
• Drug selection
• Dose
• Route
• Duration
• Culture and susceptibility results
• Surgical prophylaxis
• De-escalation when appropriate

Periodic review meetings can be conducted to discuss findings and implement corrective measures.

16. Role of Hospital Pharmacist in Infection Control

The hospital pharmacist contributes significantly to infection prevention through antimicrobial stewardship and medication management.

Responsibilities

1. Participate in Infection Control Committee meetings.
2. Assist in developing hospital antibiotic policies.
3. Promote rational antimicrobial use.
4. Monitor antibiotic utilisation.
5. Participate in Antibiotic Use Review.
6. Provide drug information regarding antimicrobials.
7. Assist in selection of appropriate antibiotics.
8. Monitor dose, duration, interactions, and adverse effects.
9. Participate in antimicrobial stewardship activities.
10. Collaborate with microbiologists regarding antimicrobial resistance patterns.
11. Support appropriate surgical antimicrobial prophylaxis.
12. Educate healthcare professionals about rational antimicrobial use.
13. Help minimise unnecessary antibiotic exposure and antimicrobial resistance.